Challenges In Analytical Development And Testing For Gene Therapies
By Stephen Gacheru, Ph.D., Vice President, Analytical Development and Technical Operations at Center for Breakthrough Medicines
Published in: Cell and Gene Newsletter
Published on: October 13, 2021
Given the rapid emergence of gene therapies based on recombinant adeno-associated virus (rAAV), there is a great need for appropriate analytical tools to support every lifecycle stage of these products.
If you have not yet signed up for the StabilityHub newsletter, join hundreds of other stabilitarians to get the latest news, publications, job opportunities and more!
By submitting this form, you are consenting to receive emails from: StabilityHub, You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact